Archive for January 1st, 2009

Chain Drug Review - Glaxo products

Thursday, January 1st, 2009

Advair HFA inhalation is now on the market. Manufactured by GlaxoSmithKline PLC, the medicine is used to treat asthma. The FDA has also approved the company’s Coreg for treating hypertension, post-myocardial infarction left ventricular dysfunction, and mild-to-severe heart attack.

Related Results

Trial data added to coreg labelNew indications for once-daily CoregFlamel Tech…